The debate here is not about the legitimacy of mRNA vaccines. It is about whether the right comparator was chosen in a clinical trial — and whether that design is sufficient for regulatory review
Source:
www.thehindu.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
Many netizens gushed over Sheh's fresh-faced glow, while others lauded her for taking time off her busy schedule to be...
ARTIFICIAL INTELLIGENCE (AI) is often hailed as the future. While we have been busy asking chatbots questions, AI has also...
"Filipiñana" has been picked up by Kino Lorber for North American distribution ahead of its European premiere at Berlinale 2026....
Significantly, the maximum contributor was a peripheral medical college hospital – Government Dharmapuri Medical College Hospital – which functions as...
There's currently a huge online battle between Southeast Asian users and South Korean netizens, with racial comments coming from both...
